Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 3,565.00
-40.00 (-1.11%)
At close: Oct 30, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 31.44 billion as of October 30, 2026. It is the 35,587th most valuable company in the world and the 2,098th biggest in South Korea. Its market cap has decreased by 43.50% in one year.
Market Cap
31.44B
Enterprise Value
16.34B
Revenue
83.17B
Global Rank
Country Rank
#2,098 South Korea
PE Ratio
132.16
ChartMarket Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 31.44B, a decrease of -54.92%. That is a compound annual growth rate of -3.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 31.44B | -45.29% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 179.14B |
| 3billion | 170.25B |
| GC Medical Science | 73.93B |
| Protia | 70.71B |
| Inventera | 62.30B |
| HLB Panagene | 57.32B |
| Cytogen | 53.54B |
| GENINUS | 46.60B |